Home » Topics » Regulatory » Patents

Patents
RSS

Cephems in development at Meiji Seika

Feb. 6, 1997

5-HT4 antagonists disclosed by Taisho

Feb. 6, 1997

Abbott's newest dopaminergic compounds described in patent literature

Feb. 6, 1997

IL-6 antagonists from Daicel

Feb. 5, 1997

Tanabe synthesizes ET antagonists

Feb. 5, 1997

PDE IV/TNF production inhibitors claimed by Pfizer

Feb. 5, 1997

Merck & Co. pursues alpha1a-adrenoceptor antagonists for BPH

Feb. 5, 1997

Pineal gland-specific gene-1 disclosed by HGS

Feb. 5, 1997

Takeda discloses novel cephems

Feb. 5, 1997

Analogues of botulinum toxin discovered with longer half-life

Feb. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...